1.27
9.48%
0.11
Handel nachbörslich:
1.28
0.01
+0.79%
Schlusskurs vom Vortag:
$1.16
Offen:
$1.15
24-Stunden-Volumen:
670.76K
Relative Volume:
2.67
Marktkapitalisierung:
$86.70M
Einnahmen:
$8.23M
Nettoeinkommen (Verlust:
$-32.49M
KGV:
-2.1525
EPS:
-0.59
Netto-Cashflow:
$-19.91M
1W Leistung:
+5.83%
1M Leistung:
+25.74%
6M Leistung:
-16.99%
1J Leistung:
+45.99%
Clearside Biomedical Inc Stock (CLSD) Company Profile
Firmenname
Clearside Biomedical Inc
Sektor
Branche
Telefon
678-270-3631
Adresse
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2021-12-15 | Fortgesetzt | Wedbush | Outperform |
2021-07-29 | Eingeleitet | H.C. Wainwright | Buy |
2020-05-13 | Eingeleitet | ROTH Capital | Buy |
2019-08-09 | Herabstufung | Needham | Buy → Hold |
2018-11-05 | Herabstufung | Cowen | Outperform → Market Perform |
2018-11-05 | Herabstufung | JP Morgan | Overweight → Underweight |
2018-11-05 | Herabstufung | Stifel | Buy → Hold |
2018-03-06 | Bestätigt | Needham | Buy |
2017-05-25 | Eingeleitet | JMP Securities | Mkt Outperform |
2017-02-24 | Eingeleitet | JP Morgan | Overweight |
2016-11-10 | Bestätigt | Needham | Buy |
2016-10-24 | Bestätigt | Stifel | Buy |
Alle ansehen
Clearside Biomedical Inc Aktie (CLSD) Neueste Nachrichten
Wall Street SWOT: Clearside Biomedical stock eyes ODYSSEY trial success - Investing.com
Armistice Capital LLC Has $2.78 Million Holdings in Clearside Biomedical, Inc. (NASDAQ:CLSD) - MarketBeat
CLSD’s Stock Market Journey: A Year of Growth, Decline, and Uncertainty - The InvestChronicle
Financial Health Report: Clearside Biomedical Inc (CLSD)’s Ratios Tell a Tale - The Dwinnex
Can Clearside's ODYSSEY Trial Data Delight Investors? - RTTNews
CLSD’s Stock Market Adventure: 5.13% YTD Growth Amidst Volatility - The InvestChronicle
Nothing is Better Than Clearside Biomedical Inc (CLSD) stock at the moment - SETE News
Clearside Biomedical, Inc. (NASDAQ:CLSD) Sees Large Increase in Short Interest - MarketBeat
Clearside Biomedical Inc [CLSD] Shares Rise 3.05 % on Thursday - Knox Daily
Was anything positive for Clearside Biomedical Inc (CLSD) stock last session? - US Post News
Clearside Biomedical Inc (CLSD) Stock: Navigating a Year of Volatility - The InvestChronicle
The Attractiveness of Investing In Clearside Biomedical Inc (CLSD) is Growing - Knox Daily
Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives Average Rating of "Buy" from Brokerages - MarketBeat
International Assets Investment Management LLC Has $26,000 Holdings in Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World
Clearside Biomedical (NASDAQ:CLSD) Share Price Crosses Below Fifty Day Moving Average of $1.12 - MarketBeat
Market Resilience: Clearside Biomedical Inc (CLSD) Finishes Weak at 0.93, Down -3.40 - The Dwinnex
Analysts review Clearside Biomedical Inc’s rating - Knox Daily
Clearside Slips on Trials - MSN
Clearside Biomedical Inc [CLSD] Investment Guide: What You Need to Know - Knox Daily
Quarterly Metrics: Quick and Current Ratios for Clearside Biomedical Inc (CLSD) - The Dwinnex
Clearside Biomedical (NASDAQ:CLSD) Given Buy Rating at HC Wainwright - Defense World
Clearside Biomedical (NASDAQ:CLSD) Receives Buy Rating from HC Wainwright - MarketBeat
Jones Trading maintains stock target, buy rating on Clearside Biomedical By Investing.com - Investing.com Canada
Jones Trading maintains stock target, buy rating on Clearside Biomedical By Investing.com - Investing.com UK
Clearside Slips on Trials - Baystreet.ca
Clearside Biomedical Announces Completion of Final - GlobeNewswire
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD - StockTitan
Assenagon Asset Management S.A. Buys Shares of 283,193 Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World
Brokers Issue Forecasts for Clearside Biomedical, Inc.'s FY2024 Earnings (NASDAQ:CLSD) - MarketBeat
Brokers Issue Forecasts for Clearside Biomedical, Inc.’s FY2024 Earnings (NASDAQ:CLSD) - Defense World
Assenagon Asset Management S.A. Takes $368,000 Position in Clearside Biomedical, Inc. (NASDAQ:CLSD) - MarketBeat
Clearside Biomedical (NASDAQ:CLSD) Earns Buy Rating from Analysts at Chardan Capital - MarketBeat
Clearside Biomedical (NASDAQ:CLSD) Research Coverage Started at Chardan Capital - Defense World
Clearside Biomedical, Inc. (NASDAQ:CLSD) Shares Bought by Vanguard Group Inc. - Defense World
Clearside Biomedical (CLSD) Stock Price, News & Analysis - MarketBeat
Clearside Biomedical, Inc. (NASDAQ:CLSD) to Post Q3 2024 Earnings of ($0.13) Per Share, HC Wainwright Forecasts - Defense World
Q3 2024 EPS Estimates for Clearside Biomedical, Inc. (NASDAQ:CLSD) Increased by Analyst - MarketBeat
Oppenheimer gives an Outperform recommendation for Clearside Biomedical Inc (CLSD) - Knox Daily
Clearside Biomedical (NASDAQ:CLSD) Receives “Buy” Rating from HC Wainwright - Defense World
Clearside Biomedical (NASDAQ:CLSD) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS - Defense World
Clearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Up 76.8% in July - Defense World
Clearside Biomedical, Inc. (NASDAQ:CLSD) Short Interest Up 76.8% in July - MarketBeat
Clearside Biomedical, Inc. (NASDAQ:CLSD) Receives $4.60 Consensus Price Target from Analysts - MarketBeat
Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Clearside Biomedical (NASDAQ:CLSD) Earns Buy Rating from Needham & Company LLC - MarketBeat
Clearside Biomedical (NASDAQ:CLSD) Posts Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Clearside Biomedical (NASDAQ:CLSD) Given Buy Rating at Needham & Company LLC - Defense World
CLSD Stock Earnings: Clearside Biomedical Beats EPS, Misses Revenue for Q2 2024 - InvestorPlace
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online
Finanzdaten der Clearside Biomedical Inc-Aktie (CLSD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):